{"id":"W4308040075","doi":"10.1016/j.anai.2022.10.018","title":"Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction","year":2022,"lang":"en","type":"article","venue":"Annals of Allergy Asthma & Immunology","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; Patient-Centered Outcomes Research Institute; Shionogi; Sanofi; Genentech; AstraZeneca; Amgen; Pfizer; GlaxoSmithKline","keywords":"Medicine; Exhaled nitric oxide; Placebo; Bronchodilator; Asthma; Dupilumab; Confidence interval; Vital capacity; Internal medicine; Gastroenterology; Hazard ratio; Anesthesia; Bronchoconstriction; Lung function; Lung; Pathology; Diffusing capacity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001360461,0.0003263499,0.0009747879,0.0001269765,0.0001812988,0.0004351133,0.0002410169,0.0004440848,0.001159245],"category_scores_gemma":[0.001298445,0.0001354748,0.000856824,0.0001371711,0.0002082199,0.0001923058,0.0001807266,0.000589853,0.0001398787],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003037346,"about_ca_system_score_gemma":0.0003657844,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004008086,"about_ca_topic_score_gemma":0.001324494,"domain_scores_codex":[0.99963,0.0001658282,0.00003445323,0.00006075424,0.00005695588,0.00005205995],"domain_scores_gemma":[0.9990643,0.0003747478,0.000296644,0.00003265672,0.00004745986,0.0001842401],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2637722,0.005098503,0.5101836,0.002743913,0.005133326,0.0008212714,0.0001887616,0.001458035,0.01322221,0.0003202754,0.007025257,0.1900326],"study_design_scores_gemma":[0.04202943,0.09256366,0.8511448,0.0002727401,0.001936952,0.00204626,0.0001118835,0.002894019,0.001424688,0.0002676133,0.005263922,0.00004395932],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9855537,0.01167002,0.0001500071,0.0003907132,0.0000793157,0.0001055218,0.0003722786,0.00002128817,0.001657238],"genre_scores_gemma":[0.9982437,0.0007869665,0.0001224543,0.0002971781,0.00008266295,0.00003485812,0.0002531351,0.000001038004,0.0001780546],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001360461,"threshold_uncertainty_score":0.007194877,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01328509330302033,"score_gpt":0.242969041617606,"score_spread":0.2296839483145857,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}